Your browser doesn't support javascript.
loading
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
Sereni, Maria Isabella; Baldelli, Elisa; Gambara, Guido; Ravaggi, Antonella; Hodge, K Alex; Alberts, David S; Guillen-Rodriguez, Jose M; Dong, Ting; Memo, Maurizio; Odicino, Franco; Angioli, Roberto; Liotta, Lance A; Pecorelli, Sergio L; Petricoin, Emanuel F; Pierobon, Mariaelena.
Affiliation
  • Sereni MI; Center for Applied Proteomics and Molecular Medicine, George Mason University, 10920 George Mason Circle, Manassas, VA 20110, USA.
  • Baldelli E; Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
  • Gambara G; Department of Obstetrics and Gynecology, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 21, 00128 Roma, Italy.
  • Ravaggi A; Center for Applied Proteomics and Molecular Medicine, George Mason University, 10920 George Mason Circle, Manassas, VA 20110, USA.
  • Hodge KA; Center for Applied Proteomics and Molecular Medicine, George Mason University, 10920 George Mason Circle, Manassas, VA 20110, USA.
  • Alberts DS; Division of Gynecologic Oncology, 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy.
  • Guillen-Rodriguez JM; Center for Applied Proteomics and Molecular Medicine, George Mason University, 10920 George Mason Circle, Manassas, VA 20110, USA.
  • Dong T; The University of Arizona Cancer Center, 3838N Campbell Ave, Tucson, AZ 85719, USA.
  • Memo M; The University of Arizona Cancer Center, 3838N Campbell Ave, Tucson, AZ 85719, USA.
  • Odicino F; Center for Applied Proteomics and Molecular Medicine, George Mason University, 10920 George Mason Circle, Manassas, VA 20110, USA.
  • Angioli R; Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
  • Liotta LA; Division of Gynecologic Oncology, 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy.
  • Pecorelli SL; Department of Obstetrics and Gynecology, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 21, 00128 Roma, Italy.
  • Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, 10920 George Mason Circle, Manassas, VA 20110, USA.
  • Pierobon M; Division of Gynecologic Oncology, 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy.
Br J Cancer ; 117(4): 494-502, 2017 Aug 08.
Article in En | MEDLINE | ID: mdl-28664915

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Signal Transduction / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Glandular and Epithelial / Proto-Oncogene Proteins c-akt / AMP-Activated Protein Kinases / TOR Serine-Threonine Kinases Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Signal Transduction / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Glandular and Epithelial / Proto-Oncogene Proteins c-akt / AMP-Activated Protein Kinases / TOR Serine-Threonine Kinases Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom